Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Unicoat Pharma ApS
APS
Active
Advertising protection
CVR 37166707
Falkevej 27A, 3400
Hillerød
Coating of metals
·
NACE 2551
Est. 2015 · 10 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Coating of metals
/
Unicoat Pharma ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
1M
1M
1M
0M
0M
1M
2021
1M
0%
2022
1M
0%
2023
1M
0%
2024
1M
0%
2025
EBITDA
DKK millions
1M
1M
1M
0M
0M
1M
2021
1M
0%
2022
1M
0%
2023
1M
0%
2024
1M
0%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
689
705
988
802
868
Staff expenses
-0
-0
-0
-0
-0
EBITDA
689
705
988
802
868
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
689
705
988
802
868
Net financials
-3
-9
9
16
4
Profit before tax
686
695
997
818
872
Tax
151
153
219
180
192
Net profit
535
542
777
638
680
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
1.155
793
904
533
1.630
Equity
290
393
577
288
507
Long-term debt
0
0
0
0
0
Short-term debt
865
400
326
245
1.123
Total debt
865
400
326
245
1.123
Financial ratios
5-year trend
EBITDA margin (of gross profit)
100.0%
This company
2021
2025
Equity ratio
31.1%
This company
38.2%
Market median
19% below market
2021
2025
Return on equity
134.1%
This company
18.4%
Market median
629% above market
2021
2025
Net profit margin (of gross profit)
78.4%
This company
2021
2025
Asset turnover (of gross profit)
0.53×
This company
2021
2025
Debt / equity
2.21×
This company
0.62×
Market median
256% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Unicoat Pharma ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
